Login

John Burt, chief executive of Abzena PLC 00:00:00

Share On Facebook Share On Twitter

John Burt, chief executive of Abzena PLC (LON:ABZA), pitches the company to investors.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Navigating through economic challenges with resilience and optimism | Manfred Knof , CEO ,  Commerzbank.
00:10:00
Greg Jensen on Innovation and Investment Strategy at Bridgewater | Investment Conference 2024
00:10:00
Companies That Transform: Alicorp Discusses Its Winning Initiative | Alfredo Perez Gubbins, CEO, ALi Corp3041:TAI
00:10:00
Comacchio Spa: Training the Next Generation of Specialized Construction Operators
00:10:00
you hear people talking about venture capital all the time|Ashley Aydin,Principal,Vamos Ventures
00:10:00
Effective Delegation for Small Business Owners: Expert Tips from Ron Bernstein | Ron Bernstein, Co-founder , Prism Planning Partners.
00:10:00
Challenging Conventional Wisdom in Wealth Strategies
00:10:00
Philippe Brassac on Crédit Agricole's Strategic Response and Universality in Challenging Times | Philippe Brassac , CEO ,  Crédit Agricole SA .
00:10:00
Activating Your Philanthropic Assets with Impact Investing | Mark Cirilli, Managing Director & Co-Founder, Mission Point Partners
00:10:00
Time one of the most crucial things when you invest on a firm|Bucky Moore,Partner, Kleiner Perkins
00:10:00
fundamentally transform the way people work|Lan Xuezhao, Managing Partner,Basis Set Ventures
00:10:00
One of the most well known VC firms focused on enterprise cloud|Santi Subotovsky,Emergence, Capital Partners

© 2017 - Neuhu+